Our project REMEDIO, which aims to develop inhaled therapies for the treatment of interstitial lung diseases, has been selected among the winners of the PNRR NODES Spoke 5 call, which focuses on innovation in the health industry and the silver economy. We are proud to have secured this opportunity to drive progress and innovation in healthcare.
